Clinical Trial Update: Technology-Based Application To Improve The Triple Therapy Adherence Rate In Subjects With Hepatitis C Infection [NA]

View source ↗

Summary

A clinical trial evaluating a technology-based application to improve adherence to hepatitis C triple therapy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: University of Louisville | Conditions: Hepatitis C | NA | Status: WITHDRAWN